BSc (Hons 1) PhD DSc (Honoris Causa) FAA
Professor John Shine was Executive Director of the Garvan Institute of Medical Research from 1990 until the end of 2011 and is Professor of Medicine and Professor of Molecular Biology at the University of NSW and Chairman of CSL Limited. He is a past Chairman of the NHMRC, past president of the Australian Genome Research Facility, and a Fellow of the Australian Academy of Science. Until 2011, he was a member of the Prime Minister’s Science, Engineering and Innovation Council. Until mid- 2016, he was President of the Museum of Applied Arts and Science (Powerhouse Museum and Sydney Observatory).
Professor Shine obtained his PhD from the Australian National University in 1975. From 1975 to 1978, at the University of California, San Francisco, Professor Shine was instrumental in the development of many of the techniques of genetic engineering. He was a central gure in the cloning of the insulin and growth hormone genes and was the rst to clone a human gene. He also determined the rst sequence responsible for replication of a cancer-causing virus.
In early 1984, Professor Shine was appointed Director of Research of a newly formed biotech company, California Biotechnology Inc. He was appointed President of the company in 1986 and guided it from a staff of some 15 scientists in 1984 to over 200 in 1987.
In 2010, Professor Shine was awarded the Prime Minister’s Prize for Science, the nation’s highest scienti c award.
Professor Shine was made a Companion (AC) in the General Division of the Order of Australia in the Queen’s Birthday Honours List 2017 for eminent service to medical research.
Professor Shine is a member of the QIMR Berghofer Appointments and Promotions Committee and the Commercialisation Committee.